Latest research report on “Vaccines Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5552201
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as foreign, destroy it, and “remember” it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This report contains market size and forecasts of Vaccines in global, including the following market information:
Global Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Vaccines Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Vaccines companies in 2021 (%)
The global Vaccines market was valued at 46590 million in 2021 and is projected to reach US$ 67140 million by 2028, at a CAGR of 5.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Recombinant Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vaccines include GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Vaccines Market Segment Percentages, by Type, 2021 (%)
– Recombinant Vaccines
– Viral Vaccines
– Polysaccharide Vaccines
Global Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Vaccines Market Segment Percentages, by Application, 2021 (%)
– Rabies vaccine
– Influenza vaccine
– HPV vaccine
– Hepatitis B
– Hepatitis A
– Leprosy vaccine
– Polio vaccine
– JE vaccine
Global Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Vaccines revenues share in global market, 2021 (%)
Key companies Vaccines sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– MedImmune LLC
– China National Biotec
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5552201
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441